Casper Breum
Gründer bei Sound Bioventures Management ApS
Profil
Casper Breum is the founder and the Managing Partner of Sound Bioventures Management ApS, which was founded in 2021.
He is currently the Director at Sanifit Therapeutics SA since 2015, VarmX BV since 2020, and Lundbeckfonden Ventures since 2009.
Mr. Breum has held former positions as the Chief Executive Officer of ilochip Bioscience A, Director at Asante Solutions, Inc., Aura Biosciences, Inc., Lundbeckfond Invest A, Lundbeck Foundation, and Nexstim Oyj.
He was also the Director at DYSIS Medical Ltd.
from 2013 to 2021, Biom'Up SA, Atox Bio Ltd.
from 2017 to 2021, and Spero Therapeutics, Inc. from 2015 to 2018.
Additionally, Mr. Breum worked as a Principal at Novo Nordisk A and Niels Clauson-Kaas A, and as the Manager-Business Development at H.
Lundbeck A.
He obtained a graduate degree from the Technical University of Denmark in 1992 and an MBA in 2001.
Aktive Positionen von Casper Breum
| Unternehmen | Position | Beginn |
|---|---|---|
Lundbeckfonden Ventures
 Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark. | Berater | 01.10.2009 |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Direktor/Vorstandsmitglied | 01.07.2015 |
Varmx BV
 Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Direktor/Vorstandsmitglied | 01.07.2020 |
| Sound Bioventures Management ApS | Gründer | 01.01.2021 |
Ehemalige bekannte Positionen von Casper Breum
| Unternehmen | Position | Ende |
|---|---|---|
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Direktor/Vorstandsmitglied | 31.10.2021 |
DYSIS Medical Ltd.
 DYSIS Medical Ltd. Medical SpecialtiesHealth Technology DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom. | Direktor/Vorstandsmitglied | 31.10.2021 |
| SPERO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 21.09.2018 |
ilochip Bioscience A/S
 ilochip Bioscience A/S SemiconductorsElectronic Technology ilochip Bioscience A/S develops lab-on-chip technology for identification of pathogens to detect bio terror agents. The company was established in September 2001 and is headquartered in Norresundby, Denmark | Vorstandsvorsitzender | 04.08.2010 |
| AURA BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Casper Breum
| Technical University of Denmark | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| H. LUNDBECK A/S | Health Technology |
| AURA BIOSCIENCES, INC. | Health Technology |
| NEXSTIM PLC | Health Technology |
| SPERO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 12 |
|---|---|
Asante Solutions, Inc.
 Asante Solutions, Inc. Medical SpecialtiesHealth Technology Asante Solutions, Inc. operated as a medical device company that focuses on the management of diabetes for patients and healthcare practitioners. The firm offered Asante Snap insulin pump system (Snap system), a pump for individuals starting insulin pump therapy and for existing pumpers. The company was founded by James L. Peterson in 2006 and was headquartered in Sunnyvale, CA. | Health Technology |
Lundbeckfond Invest A/S
 Lundbeckfond Invest A/S Investment ManagersFinance Lundbeckfond Invest A/S (Lundbeckfond Invest) is the investment management subsidiary of the Lundbeck Foundation in Denmark. Established in 1999, the firm is based in Copenhagen and manages the Lundbeck Foundation's investments, aiming for long-term, stable returns with moderate risk, such that the Foundation's net capital is not jeopardized and the Foundation is able to meet its commitments in terms of awarding grants and of laying a capital base for its subsidiaries. | Finance |
Lundbeck Foundation
 Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Miscellaneous |
DYSIS Medical Ltd.
DYSIS Medical Ltd. Medical SpecialtiesHealth Technology DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom. | Health Technology |
ilochip Bioscience A/S
ilochip Bioscience A/S SemiconductorsElectronic Technology ilochip Bioscience A/S develops lab-on-chip technology for identification of pathogens to detect bio terror agents. The company was established in September 2001 and is headquartered in Norresundby, Denmark | Electronic Technology |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Health Technology |
Niels Clauson-Kaas A/S
 Niels Clauson-Kaas A/S Miscellaneous Commercial ServicesCommercial Services Niels Clauson-Kaas A/S provides research and experimental development services in the fields of natural sciences and engineering. | Commercial Services |
Biom'Up SA
 Biom'Up SA Medical SpecialtiesHealth Technology Biom'Up SA engages in the development of hemostatic product composed of patent-protected biopolymers. Its products include Hemoblast Bellows and Hemosnow. The company was founded by Patricia Forest, Sylvain Picot and Christian Gagnieu on February 21, 2005 and is headquartered in Lyon, France. | Health Technology |
Lundbeckfonden Ventures
Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark. | Finance |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Health Technology |
Varmx BV
Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Health Technology |
| Sound Bioventures Management ApS | Finance |
